- Andrew von Eschenbach, MD, Former Commissioner of the FDA and Former Director of the National Cancer Institute
"Grisham has gone rogue, turning his formidable writing skills into an outreach to us all in an effort to shed light on a new, disruptive medical technology that has the potential to save lives. Seldom does a writer at the top of his game step away from his career to speak out on a revolutionary medical therapy. He says this is the most important book he has ever written. I believe him. This book is an amazing read!"
- Antonio Mendez, Retired CIA officer, author of ARGO
"What incredible potential to improve outcomes and quality of life for patients while decreasing the cost of care. I've seen the power of this technology firsthand with doctors at the University of Virginia. Just as that experience brought home the reality of the technology for me, John Grisham's The Tumor gives readers a better picture for what the future of medicine can look like with focused ultrasound."
- U.S. Senator Mark Warner
"Grisham's book is changing the game. He has pulled an exciting new medical technology out of the labs of academic research and onto the pages of an enlightening book. He paints a great picture of how sound waves may shape the future of medicine."
- Ed Miller, MD, former CEO, Johns Hopkins Medicine
"John emotionally captures the tremendous opportunity for Focused Ultrasound to provide a new revolutionary disruptive therapy that will improve, extend and save lives."
- Steve Rusckowski, President & CEO, Quest Diagnostics Inc.
"John Grisham utilizes his great storytelling talents to bring to life the science that may change the treatment of some of the most dreaded cancers. Grisham's view into one innovative therapy will give hope to millions about treatments that don't poison and destroy, arriving long before the yet-to-be-discovered 'individualized medicine'. The book combines fact and future in an enlightening and informative way."
- Howard Stevenson, Professor of Entrepreneurship, Emeritus, Harvard Business School
"The book is a terrific hybrid of novel and technology review. It provides a dramatic sense of the difference between what is available now and the possibility of the future. So many of us know people that could be the protagonist, that exploring the experience from the patient point of view is very compelling."
- Gordy Slack, neuroscience journalist and author
"Sooner or later many are likely to benefit from this game changing technology. Now the task at hand is to cause its development to occur as rapidly as possible. By increasing awareness, The Tumor can help make focused ultrasound available sooner to countless patients worldwide with a host of medical conditions."
- Rick Goings, CEO, Tupperware Brands
"Focused ultrasound therapy is far from fictional: It's real and rapidly gaining fame. But to see John Grisham move in this book from the legal world into medicine is to realize that the focused ultrasound story needs to be shared and there is no better way than through one of our best storytellers."
- Carol Loomis, Retired Fortune Magazine editor and writer
"A radical and potentially revolutionary view of the future of brain cancer treatment and cure. Using non-invasive focused ultrasound in the treatment of brain tumors with minimal side effects or down time seems like science fiction. In the book "The Tumor," John Grisham describes this highly innovative clinical process, which consists of applying sound waves at a frequency past the hearing capability of a human ear. The technology is no longer science fiction and may one day rewrite the outcome for cancers of the brain, breast, liver, prostate, and pancreas as well as many other serious diseases."
- Richard Merkin, MD, President and CEO of Heritage Provider Network
"John Grisham is amazing. For 25 years, he has entertained and educated us with his legal thrillers. Now, he is opening our minds to one of the most exciting medical treatments of our time. The Tumor is a quick but truly fascinating read."
- Bill Crutchfield, Founder & CEO, Crutchfield Corporation